Whitener Capital Management’s Boston Scientific BSX Stock Holding History

Whitener Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-550	Closed	-$22K	–	184
2019 Q3	$22K	Hold	550	–	–	0.01%	291
2019 Q2	$23K	Sell	550 -70	-11%	-$2.69K	0.01%	280
2019 Q1	$23K	Hold	620	–	–	0.02%	273
2018 Q4	$21K	Hold	620	–	–	0.02%	256
2018 Q3	$23K	Buy	+620	New	+$21.7K	0.02%	266
2018 Q2	–	Sell	-500	Closed	-$13K	–	160
2018 Q1	$13K	Hold	500	–	–	0.01%	309
2017 Q4	$12K	Buy	+500	New	+$13.8K	0.01%	302

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Whitener Capital Management's BSX Position: Q4 2019 in Review

Whitener Capital Management sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 550 shares — an estimated $22K sold.

Whitener Capital Management first reported a position in BSX in Q4 2017 and held it in 7 quarters. The position peaked at $23K in Q2 2019. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

Whitener Capital Management reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
Whitener Capital Management sold 550 Boston Scientific shares in Q4 2019, an estimated $22K.
Whitener Capital Management first reported a position in Boston Scientific in Q4 2017 and held it in 7 quarters.
Whitener Capital Management's Boston Scientific position peaked at $23K in Q2 2019.
853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Whitener Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.